Seroprevalence of four endemic human coronaviruses antibodies among Filipino children and their cross-reactivity and neutralization capacity against SARS-CoV-2

Author:

Sayama Yusuke1,Okamoto Michiko1,Saito Mayuko1,Saito-Obata Mariko1,Tamaki Raita2,Joboco Christine Dahlia3,Lupisan Socorro4,Oshitani Hitoshi1

Affiliation:

1. Tohoku University Graduate School of Medicine

2. Nagasaki University

3. Biliran Provincial Hospital

4. Research Institute for Tropical Medicine

Abstract

Abstract Four endemic human coronaviruses (HCoV), HCoV-229E, HCoV-NL63, HCoVHKU1, and HCoV-OC43, are closely related to SARS-CoV-2. These coronaviruses are known to infect humans living in temperate areas, including children under 5 years old; however, the seroprevalence of anti-HCoV antibodies among children in tropical areas, including the Philippines, remains unclear. This study aimed to assess the prevalence of antibodies against endemic HCoVs among Philippine children and to determine the cross-reactivity and neutralization of these antibodies against SARS-CoV-2. A total of 315 serum samples collected from 2015 to 2018 in Biliran island, Philippines, were tested for the presence of antibodies against four HCoVs and SARS-CoV-2 using recombinant spike proteins. Cross-reactivity to and neutralization of SARS-CoV-2 were also investigated. The seroprevalence of the four HCoVs was 63.8% for HCoV-229E, 71.4% for HCoV-NL63, 76.5% for HCoV-HKU1, and 83.5% for HCoV-OC43. Age group analysis indicated that seropositivity to all HCoVs reached 80% by 2–3 years of age. While 69/315 (21.9%) of the samples showed crossreactivity to SARS-CoV-2, almost no neutralization against SARSCoV-2 was detected. The high anti-HCoVs antibody levels at an early age suggest that there is earlier and higher prevalence of HCoV infections in the Philippines. Cross-reactive samples against SARS-CoV-2 indicated low neutralization capability.

Publisher

Research Square Platform LLC

Reference33 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3